Disulone

被引:11
作者
Begon, E
Chosidow, O
Wolkenstein, P
机构
[1] Hop Henri Mondor, Serv Dermatol, F-94000 Creteil, France
[2] Hop La Pitie Salpetriere, Serv Med Interne Pr Herson, F-75013 Paris, France
来源
ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE | 2004年 / 131卷 / 12期
关键词
D O I
10.1016/S0151-9638(04)93842-2
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
For 60 years, dapsone has been used as a both antibacterial and anti-inflammatory agent. Dapsone (4,4'-diaminodiphenylsulfone, DDS) continues to be used successfully to treat a wide range of dermatologic disorders, notably those characterized by abnormal neutrophil and eosinophil polynuclear accumulation. A considerable number of other inflammatory as well as bullous dermatoses, of which dermatitis herpetiformis is the best known, have been shown to respond in varying degrees to dapsone, although the indication for the molecule has not been demonstrated in of them all. This article reviews current knowledge on the pharmacokinetics, mechanism of action and side effects of dapsone in dermatology. Despite the lack of controlled studies, the aim of this study is to specify and classify the pathological states in which disulone could be indicated.
引用
收藏
页码:1062 / 1073
页数:12
相关论文
共 138 条
[1]   WELLS SYNDROME IS A DISTINCTIVE DISEASE ENTITY AND NOT A HISTOLOGIC DIAGNOSIS [J].
ABERER, W ;
KONRAD, K ;
WOLFF, K .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1988, 18 (01) :105-114
[2]   DAPSONE-INDUCED PERIPHERAL NEUROPATHY [J].
AHRENS, EM ;
MECKLER, RJ ;
CALLEN, JP .
INTERNATIONAL JOURNAL OF DERMATOLOGY, 1986, 25 (05) :314-316
[3]  
[Anonymous], 1993, ARCH DERMATOL, V129, P301
[4]   TREATMENT OF RELAPSING POLYCHONDRITIS WITH DAPSONE [J].
BARRANCO, VP ;
MINOR, DB ;
SOLOMON, H .
ARCHIVES OF DERMATOLOGY, 1976, 112 (09) :1286-1288
[5]   DAPSONE AS INITIAL TREATMENT IN SUPERFICIAL PEMPHIGUS - REPORT OF 9 CASES [J].
BASSET, N ;
GUILLOT, B ;
MICHEL, B ;
MEYNADIER, J ;
GUILHOU, JJ .
ARCHIVES OF DERMATOLOGY, 1987, 123 (06) :783-785
[6]  
Benedetti-Bardet C, 2001, THERAPIE, V56, P295
[7]   Development of dapsone toxicity in patients with inflammatory dermatoses: Activity of acetylation and hydroxylation of dapsone as risk factors [J].
Bluhm, RE ;
Adedoyin, A ;
McCarver, DG ;
Branch, RA .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1999, 65 (06) :598-605
[8]  
Bonnetblanc JM, 1999, ANN DERMATOL VENER, V126, P649
[9]   DAPSONE SUPPRESSES INTEGRIN-MEDIATED NEUTROPHIL ADHERENCE FUNCTION [J].
BOOTH, SA ;
MOODY, CE ;
DAHL, MV ;
HERRON, MJ ;
NELSON, RD .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1992, 98 (02) :135-140
[10]   Treatment of bullous pemphigoid with dapsone: Retrospective study of thirty-six cases [J].
Bouscarat, F ;
Chosidow, O ;
PicardDahan, C ;
Sakiz, V ;
Crickx, B ;
Prost, C ;
Roujeau, JC ;
Revuz, J ;
Belaich, S .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1996, 34 (04) :683-684